NSEUpdates2d ago · 5 Aug 2026, 10:28 am

Updates

Panacea Biotec Limited · PANACEABIO

✦ AI Summary

Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during July 2026'. The company has confirmed that no shares were dematerialized during the month of July 2026, with a total of 6,11,05,526 shares dematerialized as on July 31, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during July 2026'.

Attachments (1)

📄

PANACEABIO_05082026102803_DematStatusReportJuly2026signed.pdf

pdf

Download →
View document text
August 05, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai - 400 051 National Securities Depository Limited Central Depository Services (India) Ltd. Trade World, 4th Floor, Kamala Mills Marathon Futurex, A-Wing, Compound, Senapati Bapat Marg, Lower Parel, 25th Floor, NM Joshi Marg, Mumbai – 400 013 Lower Parel, Mumbai 400 013 Reg.: Details of Shares dematerialized during July 2026 Ref.: Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 Dear Sir, This is with reference to CDSL’s Operating Instructions for Issuers / RTAs, which states that the Issuer / RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we would like to inform you that no share has been dematerialized during the month of July 2026. We would also like to confirm that the total number of shares dematerialized as on July 31, 2026, were as under: NSDL 5,26,65,454 CDSL 84,40,072 Total 6,11,05,526 A copy of the certificate obtained from the Company’s RTA viz. Skyline Financial Services Pvt. Ltd., regarding shares dematerialized as on July 31, 2026, is also enclosed as Annexure -1. This is for your information and record please. Kindly acknowledge the receipt. Thanking you, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager – Legal & Company Secretary Encl.: As above Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Email: companysec@panaceabiotec.com Skyline Financial Services Pvt. Ltd S.E.B.I. REGISTERED CATEGORY-1 REGISTRARS & SHARE TRANSFER AGENT Office :D/153A, 1st Floor, Okhla Industrial Area, Phase – I, New Delhi – 110 020.. Tel. : +91-11-40450195/Fax +91-11-26812682 | CIN :U74899DL1995PTC071324 Email : info@skylinerta.com : website : www.skylinerta.com 04 August 2026 INE922B01023 THE COMPANY SECRETARY PANACEA BIOTEC LIMITED B-1 EXTN A-27 MOHAN CO-OPERATIVE INDUSTRIAL ESTAT MATHURA ROAD BADARPUR NEW DELHI 110044 DEAR SIR/MADAM, THE DEMAT STATUS REPORT OF YOUR COMPANY IS AS GIVEN BELOW: AS ON AS ON CHANGE IN 30/06/2026 31/07/2026 TOTAL NSDL 52478317 52665454 CDSL 8627209 8440072 -------------------------------------------------------- TOTAL 61105526 61105526 0 --------------------------------------------------------